up only .03 cents
I assume that means you passed up yet another great buying opportunity?
What do you expect? They are just R & D right now with a promising pipeline and no revenue but mark my word that the closer they get to FDA approval of Ganetespib the more this stock will climb which will more than likely be sometime next year.
Sentiment: Strong Buy
I see thanks for the effort, but still great!
soon you will lose your you shirts before you shorts.